To further validate the role of ATF3 in CCDC86-mediated glycolysis, LDHA, PKM2, and ALDOA levels were assessed in glioma cells with ATF3 knockdown, CCDC86 overexpression, or both. This evidence concerns the gene ALDOA and central nervous system cancer.